{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:16:28Z","timestamp":1794244588677,"version":"4.9.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"UCL Translational Acceleration Support Fund"},{"name":"UCL Technology Fund"},{"DOI":"10.13039\/501100013347","name":"European Society of Intensive Care Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sepsis-induced cardiomyopathy (SIM) is characterized by myocardial dysfunction, diminished catecholamine responsiveness and worse outcomes. Hypocholesterolemia is also a well-recognized prognosticator of poor outcomes in sepsis. In vitro physiology\/pharmacology studies indicate that low cholesterol levels within the cardiomyocyte membrane regulate \u00df-adrenergic receptor activity. We therefore hypothesized that cardiomyocyte membrane cholesterol levels are reduced in sepsis and this contributes to SIM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cardiovascular biomarkers and plasma lipid profiles measured sequentially (6, 24 and 72\u00a0h) in a fluid-resuscitated rat model of fecal peritonitis were compared against those measured in 27 septic patients on Days 1\u20133 of ICU admission. In separate studies, rat hearts were excised at the same time points for measurement of cardiomyocyte membrane cholesterol and downstream adrenergic signaling. In a final study, the impact of a 15-hour infusion of cholesterol, either given as HDL-cholesterol or liposomal cholesterol, commencing at 6\u00a0h post-sepsis induction, on dobutamine responsiveness and cardiomyocyte membrane cholesterol levels was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The magnitude of fall in stroke volume, rise in heart rate, plasma troponin and BNP, and fall in plasma HDL-cholesterol on ICU Day 1 in septic patients and at 6\u00a0h in the rat model all prognosticated for poor outcomes. In parallel, cardiomyocyte membrane cholesterol fell in the rats, more so in poor prognosis animals, with a blunted inotropic response to dobutamine, indicative of SIM. Cholesterol administration restored cardiomyocyte membrane cholesterol, dobutamine responsiveness and adrenergic signaling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In a long-term rat model of sepsis, that parallels changes seen in septic patients, cardiomyocyte membrane cholesterol fell with associated decreases in catecholamine responsiveness. These features could be restored by cholesterol infusion, suggesting potential utility as a therapeutic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-025-05638-7","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:11:30Z","timestamp":1758805890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sepsis-induced hypocholesterolemia is linked to low cardiomyocyte membrane cholesterol and impaired catecholamine responsiveness"],"prefix":"10.1186","volume":"29","author":[{"given":"Anna","family":"Kleyman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Pisciotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Gaupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqas","family":"Khaliq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hofmaenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brealey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo Bollen","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide Tommaso","family":"Andreis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Gerard","family":"Waugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda J.","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muska","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klea","family":"Mehmetaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Press","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervyn","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"5638_CR1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41569-020-00492-2","volume":"18","author":"SM Hollenberg","year":"2021","unstructured":"Hollenberg SM, Singer M. Pathophysiology of sepsis-induced cardiomyopathy. Nat Rev Cardiol. 2021;18:424\u201334.","journal-title":"Nat Rev Cardiol"},{"key":"5638_CR2","first-page":"290","volume":"27","author":"A Daulasim","year":"2021","unstructured":"Daulasim A, Vieillard-Baron A, Geri G. Hemodynamic clinical phenotyping in septic shock. Curr Opin Crit Care. 2021;27:290\u20137.","journal-title":"Curr Opin Crit Care"},{"issue":"7","key":"5638_CR3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/eurheartj\/ehr351","volume":"33","author":"G Landesberg","year":"2012","unstructured":"Landesberg G, Gilon D, Meroz Y, Georgieva M, Levin PD, Goodman S, et al. Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J. 2012;33(7):895\u2013903.","journal-title":"Eur Heart J"},{"issue":"1","key":"5638_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.hrtlng.2014.10.002","volume":"44","author":"O Sheyin","year":"2015","unstructured":"Sheyin O, Davies O, Duan W, Perez X. The prognostic significance of troponin elevation in patients with sepsis: a meta-analysis. Heart Lung. 2015;44(1):75\u201381.","journal-title":"Heart Lung"},{"issue":"3","key":"5638_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/cc11331","volume":"16","author":"F Wang","year":"2012","unstructured":"Wang F, Wu Y, Tang L, Zhu W, Chen F, Xu T, et al. Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis. Crit Care. 2012;16(3):R74.","journal-title":"Crit Care"},{"issue":"5","key":"5638_CR6","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00134-008-1022-y","volume":"34","author":"A Cariou","year":"2008","unstructured":"Cariou A, Pinsky MR, Monchi M, Laurent I, Visonneau C, Chiche J-D, et al. Is myocardial adrenergic responsiveness depressed in human septic shock? Intensive Care Med. 2008;34(5):917\u201322.","journal-title":"Intensive Care Med"},{"issue":"6","key":"5638_CR7","doi-asserted-by":"publisher","first-page":"H1224","DOI":"10.1152\/ajpheart.00828.2016","volume":"312","author":"M Sakai","year":"2017","unstructured":"Sakai M, Suzuki T, Kengo T, Yamashita S, Palikhe S, Hattori K, et al. Diminished responsiveness to Dobutamine as an Inotrope in mice with cecal ligation and puncture-induced sepsis: attribution to phosphodiesterase 4 upregulation. Am J Physiol Heart Circ Physiol. 2017;312(6):H1224\u201337.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"5638_CR8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/SHK.0000000000001718","volume":"56","author":"X Tang","year":"2021","unstructured":"Tang X, Xu Y, Dai X, Xing Y, Yang D, Huang Q, et al. The long-term effect of Dobutamine on intrinsic myocardial function and myocardial injury in septic rats with myocardial dysfunction. Shock. 2021;56(4):582\u201392.","journal-title":"Shock"},{"issue":"2","key":"5638_CR9","volume":"5","author":"DA Hofmaenner","year":"2023","unstructured":"Hofmaenner DA, Arina P, Kleyman A, Black LP, Salomao R, Tanaka S, et al. Association between hypocholesterolemia and mortality in critically ill patients with sepsis: a systematic review and meta-analysis. Crit Care Explor. 2023;5(2):e0860.","journal-title":"Crit Care Explor"},{"key":"5638_CR10","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.202105-1197TR","volume":"205","author":"DA Hofmaenner","year":"2022","unstructured":"Hofmaenner DA, Kleyman A, Press A, Bauer M, Singer M. The many roles of cholesterol in sepsis: a review. Am J Respir Crit Care Med. 2022;205:388\u201396.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"5638_CR11","first-page":"2179","volume":"64","author":"AJ Brown","year":"2010","unstructured":"Brown AJ, Galea AM. Cholesterol as an evolutionary response to living with oxygen. Evolution. 2010;64(7):2179\u201383.","journal-title":"Evolution"},{"issue":"1","key":"5638_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0891-5849(91)90187-8","volume":"11","author":"LL Smith","year":"1991","unstructured":"Smith LL. Another cholesterol hypothesis: cholesterol as antioxidant. Free Radic Biol Med. 1991;11(1):47\u201361.","journal-title":"Free Radic Biol Med"},{"key":"5638_CR13","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1096\/fj.11-191957","volume":"26","author":"M Weber","year":"2012","unstructured":"Weber M, Lambeck S, Ding N, Henken S, Kohl M, Deigner HP, et al. Hepatic induction of cholesterol biosynthesis reflects a remote adaptive response to Pneumococcal pneumonia. FASEB J. 2012;26:2424\u201336.","journal-title":"FASEB J"},{"key":"5638_CR14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ceb.2010.05.004","volume":"22","author":"FR Maxfield","year":"2010","unstructured":"Maxfield FR, van Meer G. Cholesterol, the central lipid of mammalian cells. Curr Opin Cell Biol. 2010;22:422\u20139.","journal-title":"Curr Opin Cell Biol"},{"key":"5638_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0304-4157(85)90011-5","volume":"822","author":"PL Yeagle","year":"1985","unstructured":"Yeagle PL. Cholesterol and the cell membrane. Biochim Biophys Acta. 1985;822:267\u201387.","journal-title":"Biochim Biophys Acta"},{"key":"5638_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrm2330","volume":"9","author":"G van Meer","year":"2008","unstructured":"van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. 2008;9:112\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5638_CR17","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.bbamem.2015.03.029","volume":"1848","author":"J Grouleff","year":"2015","unstructured":"Grouleff J, Irudayam SJ, Skeby KK, Schi\u00f8tt B. The influence of cholesterol on membrane protein structure, function, and dynamics studied by molecular dynamics simulations. Biochim Biophys Acta. 2015;1848:1783\u201395.","journal-title":"Biochim Biophys Acta"},{"key":"5638_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.chemphyslip.2013.02.007","volume":"169","author":"EJ Denning","year":"2013","unstructured":"Denning EJ, Beckstein O. Influence of lipids on protein-mediated transmembrane transport. Chem Phys Lipids. 2013;169:57\u201371.","journal-title":"Chem Phys Lipids"},{"key":"5638_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrn2059","volume":"8","author":"JA Allen","year":"2007","unstructured":"Allen JA, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci. 2007;8:128\u201340.","journal-title":"Nat Rev Neurosci"},{"key":"5638_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1677\/JME-08-0114","volume":"42","author":"B Chini","year":"2009","unstructured":"Chini B, Parenti M. G-protein-coupled receptors, cholesterol and palmitoylation: facts about fats. J Mol Endocrinol. 2009;42:371\u20139.","journal-title":"J Mol Endocrinol"},{"key":"5638_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.bjp.0705930","volume":"143","author":"RS Ostrom","year":"2004","unstructured":"Ostrom RS, Insel PA. The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol. 2004;143:235\u201345.","journal-title":"Br J Pharmacol"},{"key":"5638_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.chemphyslip.2014.10.004","volume":"184","author":"T Rog","year":"2014","unstructured":"Rog T, Vattulainen I. Cholesterol, sphingolipids, and glycolipids: what do we know about their role in raft-like membranes? Chem Phys Lipids. 2014;184:82\u2013104.","journal-title":"Chem Phys Lipids"},{"key":"5638_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/35036052","volume":"1","author":"K Simons","year":"2000","unstructured":"Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1:31\u201341.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5638_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrn2059","volume":"8","author":"AJ Allen","year":"2007","unstructured":"Allen AJ, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci. 2007;8:128\u201340.","journal-title":"Nat Rev Neurosci"},{"key":"5638_CR25","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1126\/science.1150577","volume":"318","author":"V Cherezov","year":"2007","unstructured":"Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SGF, Thian FS, Kobilka TS, et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science. 2007;318:1258\u201365.","journal-title":"Science"},{"key":"5638_CR26","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/prot.24456","volume":"82","author":"X Cang","year":"2014","unstructured":"Cang X, Yang L, Yang J, Luo C, Zheng M, Yu K, et al. Cholesterol-beta1AR interaction versus cholesterol-beta2 AR interaction. Proteins. 2014;82:760\u201370.","journal-title":"Proteins"},{"key":"5638_CR27","doi-asserted-by":"publisher","first-page":"34280","DOI":"10.1074\/jbc.M201644200","volume":"277","author":"Y Xiang","year":"2002","unstructured":"Xiang Y, Rybin VO, Steinberg SF, Kobilka B. Caveolar localization dictates physiologic signalling of beta 2-adrenoceptors in neonatal cardiac myocytes. J Biol Chem. 2002;277:34280\u20136.","journal-title":"J Biol Chem"},{"key":"5638_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.yjmcc.2008.04.004","volume":"45","author":"S Calaghan","year":"2008","unstructured":"Calaghan S, Kozera L, White E. Compartmentalisation of cAMP-dependent signaling by caveolae in the adult cardiac myocyte. J Mol Cell Cardiol. 2008;45:88\u201392.","journal-title":"J Mol Cell Cardiol"},{"key":"5638_CR29","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1126\/science.1185988","volume":"327","author":"VO Nikolaev","year":"2010","unstructured":"Nikolaev VO, Moshkov A, Lyon AR, Miragoli M, Novak P, Paur H, et al. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science. 2010;327:1653\u201357.","journal-title":"Science"},{"key":"5638_CR30","doi-asserted-by":"publisher","first-page":"19846","DOI":"10.1074\/jbc.M313440200","volume":"279","author":"RS Ostrom","year":"2004","unstructured":"Ostrom RS, Bundey RA, Insel PA. Nitric oxide inhibition of adenylyl cyclase type 6 activity is dependent upon lipid rafts and caveolin signalling complexes. J Biol Chem. 2004;279:19846\u201353.","journal-title":"J Biol Chem"},{"key":"5638_CR31","doi-asserted-by":"publisher","first-page":"41447","DOI":"10.1074\/jbc.M006951200","volume":"275","author":"VO Rybin","year":"2000","unstructured":"Rybin VO, Xu X, Lisanti MP, Steinberg SF. Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signalling pathway. J Biol Chem. 2000;275:41447\u201357.","journal-title":"J Biol Chem"},{"key":"5638_CR32","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1042\/CS20120334","volume":"124","author":"A Rudiger","year":"2013","unstructured":"Rudiger A, Dyson A, Felsmann K, Carre JE, Taylor V, Hughes S, et al. Early functional and transcriptomic changes in the myocardium predict outcome in a long-term rat model of sepsis. Clin Sci. 2013;124:391\u2013401.","journal-title":"Clin Sci"},{"issue":"Suppl 1","key":"5638_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/2197-425X-3-S1-A799","volume":"3","author":"DT Andreis","year":"2015","unstructured":"Andreis DT, Khaliq W, Singer M. Acute haemodynamic effects of dobutamine in experimental sepsis-induced myocardial depression. ICMx. 2015;3(Suppl 1):A799. https:\/\/doi.org\/10.1186\/2197-425X-3-S1-A799.","journal-title":"ICMx"},{"issue":"8","key":"5638_CR34","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1097\/CCM.0000000000002448","volume":"45","author":"BB Pinto","year":"2017","unstructured":"Pinto BB, Dyson A, Umbrello M, Carre JE, Ritter C, Clatworthy I, et al. Improved survival in a long-term rat model of sepsis is associated with reduced mitochondrial calcium uptake despite increased energetic demand. Crit Care Med. 2017;45(8):e840\u20138.","journal-title":"Crit Care Med"},{"key":"5638_CR35","doi-asserted-by":"publisher","first-page":"12965","DOI":"10.3390\/ijms232112965","volume":"23","author":"B De Geest","year":"2022","unstructured":"De Geest B, Mishra M. Impact of high-density lipoproteins on sepsis. Int J Mol Sci. 2022;23:12965.","journal-title":"Int J Mol Sci"},{"key":"5638_CR36","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12916-023-03057-5","volume":"21","author":"A Stasi","year":"2023","unstructured":"Stasi A, Fiorentino M, Franzin R, Stafferi F, Carparelli S, Losapio R, et al. Beneficial effects of Recombinant CER-001 high-density lipoprotein infusion in sepsis: results from a bench to bedside translational research project. BMC Med. 2023;21:392.","journal-title":"BMC Med"},{"issue":"75","key":"5638_CR37","doi-asserted-by":"publisher","first-page":"eabl9322","DOI":"10.1126\/scisignal.abl9322","volume":"15","author":"L Guo","year":"2022","unstructured":"Guo L, Morin EE, Yu M, Mei L, Fawaz MV, Wang Q, et al. Replenishing HDL with synthetic HDL has multiple protective effects against sepsis in mice. Sci Signal. 2022;15(75):eabl9322.","journal-title":"Sci Signal"},{"key":"5638_CR38","doi-asserted-by":"publisher","first-page":"H866","DOI":"10.1152\/ajpheart.01232.2008","volume":"297","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, Datta G, Zhang Y, Miller AP, Mochon P, Chen Y-F, et al. Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats. Am J Physiol Heart Circ Physiol. 2009;297:H866\u2013873.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5638_CR39","doi-asserted-by":"publisher","first-page":"R514","DOI":"10.1152\/ajpregu.00445.2013","volume":"307","author":"RS Moreira","year":"2014","unstructured":"Moreira RS, Irigoyen M, Sanches TR, Volpini RA, Camara NOS, Malheiros DM, et al. Apolipoprotein A-I mimetic peptide 4F attenuates kidney injury, heart injury, and endothelial dysfunction in sepsis. Am J Physiol Regul Integr Comp Physiol. 2014;307:R514\u2013524.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"5638_CR40","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1097\/CCM.0000000000006268","volume":"52","author":"FW Guirgis","year":"2024","unstructured":"Guirgis FW, Black LP, Henson M, Bertrad A, DeVos E, Ferreira J, et al. The lipid intensive drug therapy for sepsis phase II pilot clinical trial. Crit Care Med. 2024;52:1183\u201393.","journal-title":"Crit Care Med"},{"key":"5638_CR41","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S1473-3099(18)30805-3","volume":"19","author":"PF Laterre","year":"2019","unstructured":"Laterre PF, Colin G, Dequin P-F, Dugernier TB, da Silveira SA, et al. CAL02, a novel antitoxin liposomal agent, in severe Pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial. Lancet Infect Dis. 2019;19:620\u201330.","journal-title":"Lancet Infect Dis"},{"key":"5638_CR42","first-page":"53","volume":"17","author":"W Macadam","year":"1924","unstructured":"Macadam W, Shiskin C. The cholesterol content of the blood in relation to genito-urinary sepsis. Proc R Soc Med. 1924;17:53\u20135.","journal-title":"Proc R Soc Med"},{"key":"5638_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ebiom.2017.08.013","volume":"23","author":"MM White","year":"2017","unstructured":"White MM, Geraghty P, Hayes E, Cox S, Leitch W, Alfawaz B, et al. Neutrophil membrane cholesterol content is a key factor in cystic fibrosis lung disease. EBioMed. 2017;23:173\u201384.","journal-title":"EBioMed"},{"issue":"1","key":"5638_CR44","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s13054-021-03688-1","volume":"25","author":"C Goossens","year":"2021","unstructured":"Goossens C, Weckx R, Derde S, Perre SV, Derese I, van Veldhoven PP, et al. Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate. Crit Care. 2021;25(1):252.","journal-title":"Crit Care"},{"key":"5638_CR45","doi-asserted-by":"publisher","first-page":"e97349","DOI":"10.15252\/embj.201797349","volume":"37","author":"M Amsalem","year":"2018","unstructured":"Amsalem M, Poilbout C, Ferracci G, Delmas P, Padilla F. Membrane cholesterol depletion as a trigger of Nav1.9 channel-mediated inflammatory pain. EMBO J. 2018;37:e97349.","journal-title":"EMBO J"},{"key":"5638_CR46","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.bbamem.2010.09.006","volume":"1808","author":"YD Paila","year":"2011","unstructured":"Paila YD, Jindal E, Goswami SK, Chattopadhyay A. Cholesterol depletion enhances adrenergic signaling in cardiac myocytes. Biochimica et Biophysica Acta (BBA). 2011;1808:461\u20135.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"5638_CR47","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.cellsig.2009.06.001","volume":"21","author":"B Lei","year":"2009","unstructured":"Lei B, Morris DP, Smith MP, Schwinn DA. Lipid rafts constrain basal alpha(1A)-adrenergic receptor signaling by maintaining receptor in an inactive conformation. Cell Signal. 2009;21:1532\u20139.","journal-title":"Cell Signal"},{"key":"5638_CR48","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1161\/01.RES.48.3.320","volume":"48","author":"C Rosendorff","year":"1981","unstructured":"Rosendorff C, Hoffman JJ, Verrier ED, Rouleau J, Boerboom LE. Cholesterol potentiates the coronary artery response to norepinephrine in anesthetized and conscious dogs. Circ Res. 1981;48:320\u20139.","journal-title":"Circ Res"},{"key":"5638_CR49","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/nano10020190","volume":"10","author":"CT Inglut","year":"2020","unstructured":"Inglut CT, Sorrin AJ, Kuruppu T, Vig S, Cicalo J, Ahmad H, et al. Immunological and toxicological considerations for the design of liposomes. Nanomaterials. 2020;10:190.","journal-title":"Nanomaterials"},{"key":"5638_CR50","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.yjmcc.2012.05.015","volume":"53","author":"A Reboulleau","year":"2012","unstructured":"Reboulleau A, Robert V, Benoit V, Doublet A, Grynberg A, Paul J-L, Fournier N. Involvement of cholesterol efflux pathway in the control of cardiomyocytes cholesterol homeostasis. J Mol Cell Cardiol. 2012;53:196\u2013205.","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"5638_CR51","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1042\/BCJ20170703","volume":"475","author":"KK Durham","year":"2018","unstructured":"Durham KK, Chthely KM, Trigatti BL. High-density lipoprotein protects cardiomyocytes against necrosis induced by oxygen and glucose deprivation through SR-B1, PI3K and AKT1 and 2. Biochem J. 2018;475(7):1253\u201365.","journal-title":"Biochem J"},{"issue":"1","key":"5638_CR52","doi-asserted-by":"publisher","first-page":"H31","DOI":"10.1152\/ajpheart.00521.2016","volume":"314","author":"KK Durham","year":"2018","unstructured":"Durham KK, Chathely KM, Mak KC, Momen A, Thomas CT, Zhao Y-Y, et al. HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K- and AKT-dependent manner. Am J Physiol Heart Circ Physiol. 2018;314(1):H31\u201344.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5638_CR53","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1159\/000186933","volume":"29","author":"J Vega-Moreno","year":"2022","unstructured":"Vega-Moreno J, Tirado-Cortes A, \u00c1lvarez R, Irles C, Mas-Oliva J, Ortega A. Cholesterol depletion uncouples \u03b2-dystroglycans from discrete sarcolemmal domains, reducing the mechanical activity of skeletal muscle. Cell Physiol Biochem. 2022;29:905\u201318.","journal-title":"Cell Physiol Biochem"},{"key":"5638_CR54","doi-asserted-by":"publisher","first-page":"43764","DOI":"10.1038\/srep43764","volume":"7","author":"B Hissa","year":"2017","unstructured":"Hissa B, Oakes PW, Pontes B, Ram\u00edrez-San Juan G, Gardel ML. Cholesterol depletion impairs contractile machinery in neonatal rat cardiomyocytes. Sci Rep. 2017;7:43764.","journal-title":"Sci Rep"},{"key":"5638_CR55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0079-6123(08)00417-2","volume":"170","author":"G Gimpl","year":"2008","unstructured":"Gimpl G, Reitz J, Brauer S, Trossen C. Oxytocin receptors: ligand binding, signalling and cholesterol dependence. Prog Brain Res. 2008;170:193\u2013204.","journal-title":"Prog Brain Res"},{"key":"5638_CR56","doi-asserted-by":"publisher","first-page":"6682","DOI":"10.1021\/acs.jpcb.2c03941","volume":"126","author":"S Shrivastava","year":"2022","unstructured":"Shrivastava S, Sarkar P, Preira P, Salom\u00e9 L, Chattopadhyay A. Cholesterol-dependent dynamics of the serotonin1a receptor utilizing single particle tracking: analysis of diffusion modes. J Phys Chem B. 2022;126:6682\u201390.","journal-title":"J Phys Chem B"},{"key":"5638_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/bs.ctm.2019.07.001","volume":"84","author":"A Horn","year":"2019","unstructured":"Horn A, Jaiswal JK. Structural and signaling role of lipids in plasma membrane repair. Curr Top Membr. 2019;84:67\u201398.","journal-title":"Curr Top Membr"},{"key":"5638_CR58","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/CIRCRESAHA.109.215822","volume":"107","author":"X Wang","year":"2010","unstructured":"Wang X, Xie W, Zhang Y, Lin P, Han L, Han P, et al. Cardioprotection of ischemia\/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair. Circ Res. 2010;107:76\u201383.","journal-title":"Circ Res"},{"key":"5638_CR59","doi-asserted-by":"publisher","unstructured":"Lewis AJ, Griepentrog JE, Zhang X, Angus DC, Seymour CW, Rosengart MR. Prompt Administration of Antibiotics and Fluids in the Treatment of Sepsis: A Murine Trial. Crit Care Med. 2018;46:e426\u201334. https:\/\/doi.org\/10.1097\/CCM.0000000000003004","DOI":"10.1097\/CCM.0000000000003004"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05638-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05638-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05638-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:03:40Z","timestamp":1758809020000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-025-05638-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5638"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05638-7","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical study was approved by the National Ethics Research Service Committee (reference 11\/EE\/0180).All animal experiments were performed under a Home Office Project License (PPL 70\/7029) and local University College London (UCL) Ethics Committee approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"AK, AP, MB and MS have filed a patent for the use of cholesterol analogs and carriers in septic cardiomyopathy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"399"}}